1933 Industries CEO Appointed as Chairman of the Board, Issuance of Bonus Shares
VANCOUVER, B.C., CANADA (May 3, 2019) – 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQX: TGIFF) a licensed cultivator and producer of cannabis flower and concentrates and manufacturer of hemp/CBD wellness products, is pleased to report that Mr. Brayden Sutton has been appointed Chairman of the Board of Directors, in addition to his current positions of President and Chief Executive Officer.
Issuance of Bonus Shares
The Company announces that the Board of Directors has approved the issuance of 200,000 common shares of the Company (the “Bonus Shares“) to Mr. Brayden Sutton, at a deemed price of $0.50 per Bonus Share in lieu of a cash bonus payment for 2018. The Bonus Shares will be subject to a hold period expiring on September 8, 2019.
Investor Relations Contract
The Company also announces that it entered into a consulting agreement with Westmount Capital (“Westmount”) to provide European investor relations services, commencing on May 1, 2019, for a 6-month term ending on October 31, 2019, and will be automatically renewed for another 6-month period unless terminated with due notice by either party. Investor relations services include introducing the Company to institutional investors, fund managers and family offices in Europe and the general promotion of the Company. Westmount will be granted 100,000 incentive stock options, exercisable in whole or in part on or before 2024 at an exercise price of $0.55 per share, subject to certain vesting requirements.
About 1933 Industries Inc.
1933 Industries Inc. is a vertically integrated cannabis company with operations in the United States and Canada. Operating through three subsidiary companies, 1933 Industries owns licensed medical and adult-use cannabis cultivation and production assets, proprietary hemp-based, CBD infused products, CBD extraction services and a specialized cannabis advisory firm supporting clients in security, intelligence and due diligence. The Company owns 91% of Alternative Medicine Association and 100% of both Infused MFG. and Spire Global Strategy.
For further information please contact:
Alexia Helgason, Corporate Communications Director
604-674-4756 (ext. 1)
Brayden Sutton, Director/President & CEO
604-674-4756 (ext. 1)
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
You Might Also Like
August 12, 2017